Catherine C. Turkel - 02 Sep 2022 Form 3 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Issuer symbol
LEXX
Transactions as of
02 Sep 2022
Net transactions value
$0
Form type
3
Filing time
06 Sep 2022, 12:48:40 UTC
Next filing
13 Oct 2022

No securities are beneficially owned.